AccurEdit Therapeutics
@accuredit.com
This is based on the core team's extensive experience in the entire life cycle of biopharmaceuticals and relies on an industry-level end-to-end in vivo gene editing technology platform in line with international ICH standards.
AccurEdit Therapeutics's Company Logos
AccurEdit Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#333333
Mine Shaft
51, 51, 51
0, 0, 20
0, 0, 0, 80
#A72126
Mexican Red
167, 33, 38
358, 67, 39
0, 80, 77, 35
#F7F9FA
Aqua Haze
247, 249, 250
200, 23, 97
1, 0, 0, 2
About AccurEdit Therapeutics
AccurEdit Therapeutics is dedicated to revolutionizing the treatment of severe and life-threatening diseases worldwide. With a focus on in vivo gene editing and delivery technologies, AccurEdit aims to develop safe and effective therapies for hereditary and acquired conditions. The company boasts an industry-leading end-to-end technology platform that covers RNA synthesis, editing, and delivery.
In a groundbreaking achievement, AccurEdit became the first company in China to demonstrate safe and effective systemic CRISPR gene editing in humans. The brand's commitment to patient-centric product development is evident in its pursuit of single-dose curative therapies for various diseases. AccurEdit's milestone achievements, such as initiating the first-in-human study for ART001, showcase its dedication to advancing innovative treatments.
Led by a team with extensive experience in the biopharmaceutical industry, AccurEdit Therapeutics is well-positioned to make significant contributions to global healthcare.
